Naphazoline/pheniramine

(Redirected from Naphcon-A)

Naphazoline/pheniramine, sold under the brand name Naphcon-A among others, is a combination eye drop used to help the symptoms of allergic conjunctivitis such as from hay fever.[2] It contains naphazoline and pheniramine.[2][1] It is used as an eye drop.[1] Use is not recommended for more than three days.[3]

Naphazoline/pheniramine
Combination of
NaphazolineVasoconstrictor
PheniramineAntihistamine
Clinical data
Trade namesNaphcon-A, Opcon-A, Visine-A, others
AHFS/Drugs.comMultum Consumer Information
Routes of
administration
Eye drop
Legal status
Legal status
Identifiers
CAS Number

Side effects may include allergic reactions, eye pain, and dilated pupils.[2][4][3] It is unclear if use in pregnancy is safe.[1] Nephazoline works by resulting in constriction of blood vessels thus decreasing redness while pheniramine works by blocking the effects of histamine to stop itching.[1]

The combination was approved for medical use in the United States in 1994.[5][6][1] It is available over the counter.[5][6][2] In 2017, it was the 203rd most commonly prescribed medication in the United States, with more than two million prescriptions.[7][6]

Medical use

edit

It is administered topically with one to two drops applied to the affected eye(s) up to four times daily.[2]

Adverse effects

edit

References

edit
  1. ^ a b c d e f "Naphazoline and pheniramine ophthalmic Uses, Side Effects & Warnings". Drugs.com. Retrieved 19 April 2019.
  2. ^ a b c d e f "Naphcon A- naphazoline hydrochloride and pheniramine maleate solution/ drops". DailyMed. 16 September 2019. Retrieved 10 August 2020.
  3. ^ a b Kizior RJ, Hodgson BB (2014). Saunders Nursing Drug Handbook 2015 - E-Book. Elsevier Health Sciences. p. 163. ISBN 9780323280181.
  4. ^ "Naphazoline/pheniramine ophthalmic Side Effects in Detail". Drugs.com. Retrieved 19 April 2019.
  5. ^ a b "Naphcon-A: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 19 April 2020.
  6. ^ a b c "Naphazoline Hydrochloride; Pheniramine Maleate - Drug Usage Statistics". ClinCalc. Retrieved 11 April 2020.
  7. ^ "The Top 300 of 2020". ClinCalc. Retrieved 11 April 2020.
edit